Analytical Data
-
基因名
FLJ10719
- Application
-
别名
FANCI; FANCI gene; FANCI_HUMAN; Fanconi anemia group I protein; Fanconi anemia; complementation group I; FLJ10719; FLJ14658; KIAA1794; Protein FACI; Protein FANCI
-
种属
Human
-
表达系统
E. coli
-
标签
GST-tag at N-terminal
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q9NVI1
-
表达区间
1-73aa
-
氨基酸序列
MFKDVPLTAEEVEFVVEKALSMFSKMNLQEIPPLVYQLLVLSSKGSRKSVLEGIIAFFSALDKQHNEEQSGDE
-
分子量
33.77 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
The FLJ10719 protein, also known as C1orf109, has garnered attention in molecular biology and biochemical research due to its potential role in various cellular processes. Initially identified through genomic sequencing projects, FLJ10719 is characterized as a human gene that encodes a protein of unknown function. Recent studies have begun to elucidate its possible involvement in cellular signaling pathways, immune responses, and its implications in disease mechanisms, particularly in cancer and autoimmune disorders. The protein's expression patterns, cellular localization, and interaction with other biomolecules have been subjects of investigation, revealing insights into its functional significance. Further research could unlock its potential as a biomarker for disease states or therapeutic target. Understanding FLJ10719 is crucial, as it may contribute to the broader understanding of human health and disease, underscoring the importance of ongoing investigations into its biological roles and mechanisms of action.
